Aberrant production of soluble co-stimulatory molecules CTLA-4 and CD28 in patients with chronic hepatitis B

Microbial Pathogenesis

Volumn 51, Issue 4, 2011, Pages 262-267

  Cao, Ju ^a   Zhang, Liping ^a   Huang, Shifeng ^a   Chen, Pu ^a   Zou, Lin ^a   Chen, Hui ^a   Xiang, Yu ^a   Lai, Xiaofei ^a   Ren, Guosheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Co stimulatory molecules; HBV; Immune response; Infection

Indexed keywords

ALANINE AMINOTRANSFERASE; B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EX VIVO STUDY; FEMALE; HEPATITIS B; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; PROTEIN SYNTHESIS; VIRUS PATHOGENESIS;

ADULT; ALANINE TRANSAMINASE; ANTIGENS, CD28; ANTIGENS, CD86; CTLA-4 ANTIGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED;

HEPATITIS B VIRUS;

EID: 79960928006     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2011.06.003     Document Type: Article

References (45)

1. Lok A.S. The maze of treatments for hepatitis B. N Engl J Med 2005, 352:2743-2746.
2. Wursthorn K., Wedemeyer H., Manns M.P. Managing HBV in patients with impaired immunity. Gut 2010, 59:1430-1445.
3. Rehermann B. Intrahepatic T cells in hepatitis B: viral control versus liver cell injury. J Exp Med 2000, 191:1263-1268.
4. Frebel H., Richter K., Oxenius A. How chronic viral infections impact on antigen-specific T-cell responses. Eur J Immunol 2010, 40:654-663.
5. Zhang J.Y., Zhang Z., Lin F., Zou Z.S., Xu R.N., Jin L., et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010, 51:81-91.
6. Op den Brouw M.L., Binda R.S., van Roosmalen M.H., van Roosmalen M.H., Protzer U., Janssen H.L., et al. Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus. Immunology 2009, 126:280-289.
7. Tjwa E.T., van Oord G.W., Hegmans J.P., Janssen H.L., Woltman A.M. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J Hepatol 2011, 54:209-218.
8. Chen M., Zhang D., Zhen W., Shi Q., Liu Y., Ling N., et al. Characteristics of circulating T cell receptor gamma-delta T cells from individuals chronically infected with hepatitis B virus (HBV): an association between V(delta)2 subtype and chronic HBV infection. J Infect Dis 2008, 198:1643-1650.
9. Klein J., Sato A. The HLA system. First of two parts. N Engl J Med 2000, 343:702-709.
10. Klein J., Sato A. The HLA system. Second of two parts. N Engl J Med 2000, 343:782-786.
11. Chambers C.A., Allison J.P. Co-stimulation in T cell responses. Curr Opin Immunol 1997, 9:396-404.
12. Keir M.E., Sharpe A.H. The B7/CD28 costimulatory family in autoimmunity. Immunol Rev 2005, 204:128-143.
13. Linsley P.S., Clark E.A., Ledbetter J.A. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci USA 1990, 87:5031-5035.
14. Greenfield E.A., Nguyen K.A., Kuchroo V.K. CD28/B7 costimulation: a review. Crit Rev Immunol 1998, 18:389-418.
15. Salomon B., Bluestone J.A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001, 19:225-252.
16. Walunas T.L., Bakker C.Y., Bluestone J.A. CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 1996, 183:2541-2550.
17. Linsley P.S., Brady W., Urnes M., Grosmaire L.S., Damle N.K., Ledbetter J.A. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991, 174:561-569.
18. Barboza L., Salmen S., Peterson D.L., Montes H., Colmenares M., Hernández M., et al. Altered T cell costimulation during chronic hepatitis B infection. Cell Immunol 2009, 257:61-68.
19. Hsu P.N., Yang T.C., Kao J.T., Cheng K.S., Lee Y.J., Wang Y.M., et al. Increased PD-1 and decreased CD28 expression in chronic hepatitis B patients with advanced hepatocellular carcinoma. Liver Int 2010, 30:1379-1386.
20. Schott E., Witt H., Pascu M., van Boemmel F., Weich V., Bergk A., et al. Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease. Eur J Gastroenterol Hepatol 2007, 19:947-951.
21. Thio C.L., Mosbruger T.L., Kaslow R.A., Karp C.L., Strathdee S.A., Vlahov D., et al. Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection. J Virol 2004, 78:11258-11262.
22. Wang F.S., Xing L.H., Liu M.X., Zhu C.L., Liu H.G., Wang H.F., et al. Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J Gastroenterol 2001, 7:537-541.
23. Duan X.Z., Zhuang H., Wang M., Li H.W., Liu J.C., Wang F.S. Decreased numbers and impaired function of circulating dendritic cell subsets in patients with chronic hepatitis B infection (R2). J Gastroenterol Hepatol 2005, 20:234-242.
24. Oaks M.K., Hallett K.M., Penwell R.T., Stauber E.C., Warren S.J., Tector A.J. A native soluble form of CTLA-4. Cell Immunol 2000, 201:144-153.
25. Hebbar M., Jeannin P., Magistrelli G., Hatron P.Y., Hachulla E., Devulder B., et al. Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis. Clin Exp Immunol 2004, 136:388-392.
26. McHugh R.S., Ratnoff W.D., Gilmartin R., Sell K.W., Selvaraj P. Detection of a soluble form of B7-1 (CD80) in synovial fluid from patients with arthritis using monoclonal antibodies against distinct epitopes of human B7-1. Clin Immunol Immunopathol 1998, 87:50-59.
27. Hock B.D., Patton W.N., Budhia S., Mannari D., Roberts P., McKenzie J.L. Human plasma contains a soluble form of CD86 which is present at elevated levels in some leukaemia patients. Leukemia 2002, 16:865-873.
28. Faas S.J., Giannoni M.A., Mickle A.P., Kiesecker C.L., Reed D.J., Wu D., et al. Primary structure and functional characterization of a soluble, alternatively spliced form of B7-1. J Immunol 2000, 164:6340-6348.
29. Wong C.K., Ho A.W., Tong P.C., Yeung C.Y., Chan J.C., Kong A.P., et al. Aberrant expression of soluble co-stimulatory molecules and adhesion molecules in type 2 diabetic patients with nephropathy. J Clin Immunol 2008, 28:36-43.
30. Wong C.K., Lun S.W., Ko F.W., Ip W.K., Hui D.S., Lam C.W. Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma. Clin Exp Immunol 2005, 141:122-129.
31. Chen Z., Zhou F., Huang S., Jiang T., Chen L., Ge L., et al. Association of cytotoxic T lymphocyte associated antigen-4 gene (rs60872763) polymorphism with Crohn's disease and high levels of serum sCTLA-4 in Crohn's disease. J Gastroenterol Hepatol 2011, 26:924-930.
32. Erfani N., Razmkhah M., Ghaderi A. Circulating soluble CTLA4 (sCTLA4) is elevated in patients with breast cancer. Cancer Invest 2010, 28:828-832.
33. Schlaak J.F., Tully G., Löhr H.F., Gerken G. Meyer zum Büschenfelde KH. HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines. Clin Exp Immunol 1999, 115:508-514.
34. Kim W.R., Flamm S.L., Di Bisceglie A.M., Bodenheimer H.C. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 2008, 47:1363-1370.
35. Magistrelli G., Jeannin P., Elson G., Gauchat J.F., Nguyen T.N., Bonnefoy J.Y., et al. Identification of three alternatively spliced variants of human CD28 mRNA. Biochem Biophys Res Commun 1999, 259:34-37.
36. Magistrelli G., Jeannin P., Herbault N., Benoit De Coignac A., Gauchat J.F., Bonnefoy J.Y., et al. A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur J Immunol 1999, 29:3596-3602.
37. Linsley P.S., Nadler S.G. The clinical utility of inhibiting CD28-mediated costimulation. Immunol Rev 2009, 229:307-321.
38. Duttagupta P.A., Boesteanu A.C., Katsikis P.D. Costimulation signals for memory CD8+ T cells during viral infections. Crit Rev Immunol 1999, 29:469-486.
39. Jan R.H., Lin Y.L., Chen L.K., Huang M.T., Wang L.C., Chiang B.L. Hepatitis B virus surface antigen can activate dendritic cells and modulate T helper type immune response. Microbiol Immunol 2011, 55:51-59.
40. Li J., Wu W., Peng G., Chen F., Bai M., Zheng M., et al. HBcAg induces interleukin-10 production, inhibiting HBcAg-specific Th17 responses in chronic hepatitis B patients. Immunol Cell Biol 2010, 88:834-841.
41. Tang Y., Chen Y., Ni B., Yang D., Guo S., Wu Y. Up-regulation of the expression of costimulatory molecule CD40 in hepatocytes by hepatitis B virus X antigen. Biochem Biophys Res Commun 2009, 384:12-17.
42. Tan A.T., Koh S., Goh W., Zhe H.Y., Gehring A.J., Lim S.G., et al. A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. J Hepatol 2010, 52:330-339.
43. TrehanPati N., Geffers R., Sukriti, Hissar S., Riese P., Toepfer T., et al. Gene expression signatures of peripheral CD4+ T cells clearly discriminate between patients with acute and chronic hepatitis B infection. Hepatology 2009, 49:781-790.
44. Song le H., Binh V.Q., Duy D.N., Kun J.F., Bock T.C., Kremsner P.G., et al. Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus. J Clin Virol 2003, 28:93-103.
45. Sakthivel P., Wermeling F., Elmgren A., Hulthe J., Kakoulidou M., Lefvert A.K., et al. Circulating soluble CTLA-4 is related to inflammatory markers in the 70 year old population. Scand J Clin Lab Invest 2010, 70:237-243.